SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-9.52%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$649M
AUM Growth
+$649M
(-12%)
Cap. Flow
-$4.85M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
84
New
16
Increased
18
Reduced
18
Closed
18
Top Buys
| 1 |
United Therapeutics
UTHR
|
$25.4M |
| 2 |
Illumina
ILMN
|
$21.8M |
| 3 |
OraSure Technologies
OSUR
|
$20.7M |
| 4 |
Hologic
HOLX
|
$17.3M |
| 5 |
Arcellx
ACLX
|
$13.9M |
Top Sells
| 1 |
Lantheus
LNTH
|
$87.7M |
| 2 |
AstraZeneca
AZN
|
$24.3M |
| 3 |
C4 Therapeutics
CCCC
|
$9.57M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$8.24M |
| 5 |
Smith & Nephew
SNN
|
$6.64M |
Sector Composition
| 1 | Healthcare | 95.72% |
| 2 | Financials | 0.6% |
| 3 | Consumer Staples | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $54.9M | 7.08% | 305,850 +141,550 | +86% | +$25.4M |
|
2
ESSA Pharma
EPIX
$11.4M
| $26.1M | 3.37% | 4,223,799 +698,342 | +20% | +$4.32M |
|
3
Surmodics
SRDX
$487M
| $25.3M | 3.27% | 558,440 +25,683 | +5% | +$1.16M |
|
|
EDAP
4
EDAP TMS
EDAP
$84.5M
| $22.8M | 2.94% | 3,148,609 | – | – |
|
5
AngioDynamics
ANGO
$417M
| $22.1M | 2.85% | 1,026,450 +511,000 | +99% | +$11M |
|
|
6
Illumina
ILMN
$15.8B
| $21.8M | 2.81% | +62,300 | New | +$21.8M |
|
|
7
OraSure Technologies
OSUR
$242M
| $20.7M | 2.67% | +3,055,193 | New | +$20.7M |
|
8
Organogenesis Holdings
ORGO
$653M
| $19.4M | 2.5% | 2,540,167 +541,080 | +27% | +$4.12M |
|
9
iRadimed
IRMD
$921M
| $19.3M | 2.49% | 430,051 -19,979 | -4% | -$896K |
|
10
Krystal Biotech
KRYS
$4.27B
| $19.3M | 2.48% | 289,337 +60,900 | +27% | +$4.05M |
|
11
Neuropace
NPCE
$303M
| $19.1M | 2.46% | 2,324,003 +15,000 | +0.6% | +$123K |
|
|
THER
12
DELISTED
THERATECHNOLOGIES INC COM
THER
| $18.8M | 2.43% | 7,692,082 | – | – |
|
|
DICE
13
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $18.8M | 2.43% | 983,994 +173,054 | +21% | +$3.31M |
|
|
APEN
14
DELISTED
Apollo Endosurgery, Inc.
APEN
| $17.5M | 2.26% | 2,893,100 +598,000 | +26% | +$3.62M |
|
|
15
Hologic
HOLX
$14.9B
| $17.3M | 2.24% | +225,600 | New | +$17.3M |
|
|
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $16.2M | 2.09% | 964,476 -103,900 | -10% | -$1.75M |
|
17
Evolus
EOLS
$494M
| $15.4M | 1.98% | 1,368,389 +109,500 | +9% | +$1.23M |
|
|
18
Enanta Pharmaceuticals
ENTA
$180M
| $14.4M | 1.86% | 202,485 -115,790 | -36% | -$8.24M |
|
19
Nurix Therapeutics
NRIX
$714M
| $14.2M | 1.83% | 1,011,638 +268,400 | +36% | +$3.76M |
|
|
20
Arcellx
ACLX
$3.85B
| $13.9M | 1.79% | +989,739 | New | +$13.9M |
|
21
FibroGen
FGEN
$47.8M
| $12.8M | 1.65% | 1,064,356 -486,141 | -31% | -$5.84M |
|
22
BioAtla
BCAB
$26.7M
| $12.6M | 1.62% | 2,515,424 | – | – |
|
|
PVLA
23
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $12.5M | 1.62% | 4,134,868 +3,447,456 | +502% | +$10.4M |
|
24
Inspire Medical Systems
INSP
$2.77B
| $12.3M | 1.59% | 47,900 +20,450 | +74% | +$5.25M |
|
|
25
Smith & Nephew
SNN
$16.3B
| $12.3M | 1.58% | 385,000 -208,200 | -35% | -$6.64M |
|